DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20195016

The research progress on the mechanism of adenosine A1 receptor-mediated calcitonin gene-related peptide to relieve migraine

Zheng Hai Fei, Song Wei Wei, Chen Jin Bo, Zhang Ying

Abstract


Currently, the pathogenesis of migraine is unclear. The trigeminal vascular reflex theory is the dominant pathogenesis theory, and its core parts are neurogenic inflammation and pain sensitisation. Calcitonin gene related peptide (CGRP) is the most powerful vasodilating peptide in brain circulation. It is also a marker of trigeminal nerve microvascular activation that plays a synergistic role in the pathogenesis of migraine. Adenosine A1 receptor (A1R) can inhibit the release of CGRP in the trigeminal nerve vascular system to alleviate migraine by mediating adenosine. This review summarises the progress of research on the alleviation of migraine by using A1R-mediated CGRP.


Keywords


Adenosine A1 receptor, Analgesia, Calcitonin gene-related peptide, Migraine

Full Text:

PDF

References


Jesani J, Simerson D. Pharmacologic Management of Acute Migraines in the Emergency Department. Advan emerge nurs J. 2019;41(2):150-62.

Feng C, Yue Y, Haichun MA. Analgesic effect of adenosine A1 receptor agonist administered into the brainstem medial pontine reticular formation in rats. Chin J Anesthesiol. 1996;(07).

Riesco N, Cernuda-Morollón E, Pascual J. Neuropeptides as a marker for chronic headache. Curre pain headac report. 2017;21(4):18.

Malhotra R. Understanding migraine: Potential role of neurogenic inflammation. Anna Ind Acade Neurol. 2016;19(2):175.

Arulmani U, Heiligers JP, Centurión D, Garrelds IM, Villalón CM, Saxena PR. Lack of effect of the adenosine A1 receptor agonist, GR79236, on capsaicin-induced CGRP release in anaesthetized pigs. Cephalalg. 2005;25(11):1082-90.

MaassenVanDenBrink A, Terwindt GM, van den Maagdenberg AM. Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment. Gen medi. 2018;10(1):10.

Malhotra R. Understanding migraine: Potential role of neurogenic inflammation. Anna Ind Academ Neurol. 2016;19(2):175.

Karsan N, Goadsby PJ. CGRP mechanism antagonists and migraine management. Curre neurol neuroscien repor. 2015;15(5):25.

Russo AF. Calcitonin gene-related peptide (CGRP): a new target for migraine. Annul revi pharmacol toxicol. 2015;55:533-52.

Jespers W, Schiedel AC, Heitman LH, Cooke RM, Kleene L, van Westen GJ, et al. Structural mapping of adenosine receptor mutations: ligand binding and signaling mechanisms. Tren pharmacol sci. 2018 1;39(1):75-89.

Fried NT, Elliott MB, Oshinsky ML. The role of adenosine signaling in headache: a review. Brai sci. 2017;7(3):30.

Hu Liping. Adenosine A1 receptors mediate anti-nociceptive effects of moxibustion. Chengdo Univer. TCM. 2016:10-12.

Schindler M, Harris CA, Hayes B, Papotti M, Humphrey PP. Immunohistochemical localization of adenosine A1 receptors in human brain regions. Neuroscie letter. 2001;297(3):211-5.

Yamaguchi D, Terayama R, Omura S, Tsuchiya H, Sato T, Ichikawa H et al. Effect of adenosine A1 receptor agonist on the enhanced excitability of spinal dorsal horn neurons after peripheral nerve injury. Intern J Neurosc. 2014;124(3):213-22.

Goldman N, Chen M, Fujita T, Xu Q, Peng W, Liu W, et al. Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Natu neurosc. 2010;13(7):883.

Sawynok J. Adenosine receptor targets for pain. Neurosci. 2016;338:1-8.

Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Ann revie neurosci. 2001;24(1):31-55.

Wu L, Li H, Li YQ. Adenosine suppresses the response of neurons to GABA in the superficial laminae of the rat spinal dorsal horn. Neuroscie. 2003;119(1):145-54.

Zhao C, Zhao J, Yang Q, Ye Y. Cobra neurotoxin produces central analgesic and hyperalgesic actions via adenosine A1 and A2A receptors. Molecul pai. 2017;13:1744806917720336.

Zylka MJ. Pain-relieving prospects for adenosine receptors and ectonucleotidases. Tren molecu medi. 2011;17(4):188-96.

MacDonald RL, Skerritt JH, Werz MA. Adenosine agonists reduce voltage‐dependent calcium conductance of mouse sensory neurones in cell culture. J physiol. 1986;370(1):75-90.

Bin LI, Jinbo C, Xiaowen S. Analgesic effect of adenosine A1 receptor agonist into lateral ventricles in rat models of migraine. J Apopl Nervo Disea. 2016;12:1091-4.

Sodhi P. Adenosine modulates light responses of rat retinal ganglion cell photoreceptors througha cAMP-mediated pathway. J physiol. 2014,592(19):4201-20.

Cieślak M, Czarnecka J, Roszek K. The role of purinergic signaling in the etiology of migraine and novel antimigraine treatment. Purinerg signalli. 2015;11(3):307-16.

Lu W, Li B, Chen J. Expression of calcitonin gene-related peptide, adenosine A2a receptor and adenosine A1 receptor in experiment rat migraine models. Biomed Rep. 2016;4(3):379-83.